Published 2022-09-01
“…Vladislav Berdunov,1 Steve Millen,2 Andrew Paramore,2 Jane Griffin,3 Sarah Reynia,2 Nina Fryer,2 Rebecca Brown,1 Louise Longworth1 1PHMR Ltd, London, UK; 2Exact Sciences, London, UK; 3Jane Griffin Associates,
East Molesey, UKCorrespondence: Vladislav Berdunov, PHMR Ltd, Berkeley Works, Berkley Grove, London, NW1 8XY, UK, Tel +44 20 3432 7450, Email vlad.berdunov@phmr.comBackground: The 21-gene assay (the Oncotype DX Breast Recurrence Score® test) is a validated multigene assay which produces the Recurrence Score® result (RS) to inform decisions on the use of adjuvant chemotherapy in human epidermal growth factor receptor 2-negative (HER2-), hormone receptor positive (HR+) early invasive breast cancer. …”
Get full text
Article